Broad Medicare Formularies Would Negatively Impact Rx Industry – PCMA
Executive Summary
Strict formulary requirements imposed on plan sponsors under the Medicare prescription drug benefit would be self-defeating for pharmaceutical manufacturers, Pharmaceutical Care Management Association CEO Mark Merritt argued Oct. 25
You may also be interested in...
Medco Says It Is Ready For Part D: Will CMS Be?
Medco is "leaning" toward participating directly in the Medicare Part D stand-alone prescription drug insurance program in 2006, CEO David Snow said during an analyst meeting Nov. 11 in Philadelphia
Medco Says It Is Ready For Part D: Will CMS Be?
Medco is "leaning" toward participating directly in the Medicare Part D stand-alone prescription drug insurance program in 2006, CEO David Snow said during an analyst meeting Nov. 11 in Philadelphia
USP Responding To Congress’ Questions On Medicare Formulary Guidelines
The U.S. Pharmacopeia has been providing congressional committees with information as it moves toward finalizing its model formulary guidelines for the Medicare prescription drug benefit